FindMyRecallSubscribe
Class I: serious health riskOngoing

Sandoz Cefazolin for Injection Recall

Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenou…

Sandoz Inc · Princeton, NJ

Risk level
Class I
Reported by FDA
Jul 9, 2025
Recall ID
D-0569-2025
Check your lot numberHow we source this data

Summary

Sandoz recalled Cefazolin for Injection starting Jun 27, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0569-2025 on Jul 9, 2025. Reason: Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin

Product description

Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).

Lot numbers, UPCs & expiration codes

Lot # PG4360, PG4362, Exp. 11/30/2027

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0569-2025
Classification
Class I
Status
Ongoing
Recall initiated
Jun 27, 2025
FDA report date
Jul 9, 2025
Quantity
208,300 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-0569-2025, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
97140
Address
100 College Rd W
Code information
Lot # PG4360, PG4362, Exp. 11/30/2027
Postal code
08540-6604
Report date
Jul 9, 2025
Product type
Drugs
Recall number
D-0569-2025
Classification
Class I
Recalling firm
Sandoz Inc
Product quantity
208,300 vials
Reason for recall
Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 27, 2025
Initial firm notification
Press Release
Center classification date
Aug 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0569-2025, published Jul 9, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls